| Brand Name | Ositab |
| Packaging Type | Bottle |
| Molecule | Osimertinib |
| Generic Name | Osimertinib 80mg |
| Manufactured By | Azista |
| Quantity | 30 tablets |
| Form | Tablets |
| Country of Origin | Bhutan |
| Categories | Oncology |
Introduction to Ositab Osimertinib 80mg Tablets
Ositab 80mg contains Osimertinib, a third-generation EGFR tyrosine kinase inhibitor (TKI), specifically designed to target and treat non-small cell lung cancer (NSCLC) with mutations in the epidermal growth factor receptor (EGFR). Ositab 80 mg is manufactured by Azista. It is commonly used for patients with advanced stages of NSCLC, especially those who have tested positive for the T790M mutation, a genetic change that makes cancer cells resistant to earlier EGFR-TKI therapies.
Ositab 80mg works by blocking the abnormal EGFR protein signals that cause cancer cells to grow and multiply, helping to slow down or stop the spread of cancer. It is effective as a first-line treatment for metastatic NSCLC and can also be used in patients who have failed previous EGFR-targeted therapies.
Indication:
Ositab 80mg is recommended for patients with EGFR-mutated NSCLC, especially those who have experienced disease progression following previous treatment with EGFR TKIs. It serves as a therapeutic option for advanced or metastatic lung cancer, offering hope to patients who have developed resistance to previous treatments
Key Benefits:
- Specifically targets EGFR mutations in NSCLC.
- Helps slow cancer progression by inhibiting abnormal proteins.
- Potentially reduces tumor size.
- Suitable for patients who have progressed on prior EGFR-TKI therapy.
- Ositab 80mg offers a targeted and advanced solution for managing EGFR-mutated NSCLC, providing a critical option for patients who have progressed after prior treatments.
Ositab 80mg Dosage
The recommended dose is 80 mg once daily, with or without food. Ositab should be taken as prescribed by a patient’s healthcare specialist, and regular monitoring is important to ensure maximum treatment response.
How to Consume:
- Dosage: Take one 80mg tablet orally once daily, exactly as prescribed by your healthcare provider.
- Instructions: Swallow the tablet whole with water. Do not chew, crush, or break the tablet.
Side Effects of Ositab 80mg Tablet
Common side effects of Ositab 80mg may include:
- Diarrhea
- Rash
- Fatigue
- Decreased appetite
- Mouth sores (stomatitis)
- Nail toxicity
- Dry skin
- Low blood cell counts, increasing the risk of infection
- Heart problems (rare, but serious)
If any of these side effects persist or worsen, it’s crucial to consult your doctor immediately.
Ositab 80mg Precautions:
- Ositab should be used under the guidance of a healthcare provider.
- Inform the patient's doctor of any underlying medical conditions, such as lung or heart problems.
- Avoid taking the Ositab Osimertinib 80mg Tablets with certain foods or other drugs that may interfere with its effectiveness.
Osimertinib 80 mg is used to treat non-small cell lung cancer (NSCLC) with specific EGFR mutations.
Common side effects of Osimertinib include diarrhea, rash, dry skin, nail toxicity, and fatigue.
No, Tagrisso is not safe during pregnancy or breastfeeding. Use birth control while taking Tagrisso and for several weeks after your last dose.
Generic Tagrisso is not a cure for lung cancer, but it can significantly extend survival and delay disease progression in patients with advanced non-small cell lung cancer (NSCLC) with specific EGFR mutations.
No, Tagrisso is neither chemotherapy nor immunotherapy. It is a targeted therapy specifically designed to inhibit mutated EGFR in certain types of lung cancer.
Generic Tagrisso works by inhibiting the activity of mutated EGFR, which is responsible for the growth of certain types of non-small cell lung cancer. By blocking this pathway, the drug prevents cancer cells from growing and spreading.
Yes, Tagrisso works by targeting and killing cancer cells that have specific EGFR mutations, inhibiting their growth and spread in non-small cell lung cancer (NSCLC).
If you miss a dose, skip the missed dose and take your next dose at the regular time. Do not take two doses at once to make up for the missed dose.
No, Osimertinib (Tagrisso) is a prescription medication, and you need a doctor’s prescription to obtain it.
You can order Osimertinib by logging into your account on our website, adding the tablet to your cart, and proceeding to checkout. After successful payment, your order will be confirmed, and you will receive a confirmation email. You can also contact us via WhatsApp to place your order directly.
